Lotus Eye Hospital And Institute is currently trading at Rs. 113.00, up by 0.20 points or 0.18% from its previous closing of Rs. 112.80 on the BSE.
The scrip opened at Rs. 113.00 and has touched a high and low of Rs. 113.00 and Rs. 112.00 respectively. So far 1231 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 153.00 on 22-Jun-2026 and a 52 week low of Rs. 97.60 on 30-Mar-2026.
Last one week high and low of the scrip stood at Rs. 117.95 and Rs. 109.60 respectively. The current market cap of the company is Rs. 234.58 crore.
The promoters holding in the company stood at 40.14%, while Non-Institutions held 59.87% stake in the company.
Lotus Eye Hospital and Institute has launched Lotus Optique, a new optical store at its SITRA campus in Coimbatore. With Lotus Optique, the company takes its commitment to comprehensive vision care a step further by bringing professional eye care and quality eye wear together under one roof.
The optical store is designed to offer customers a curated selection of branded frames and contemporary eye wear, supported by the company’s clinical expertise and eye care environment. The store is equipped with the ZEISS VISUFIT 1000, a 3D facial scanning technology designed to assist in frame selection and fitting.
Lotus Eye Hospital and Institute is engaged in the field of ophthalmology (Eye) and its related operations.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8660.00 |
| Max Healthcare Inst. | 987.90 |
| Narayana Hrudayalay. | 1852.80 |
| Aster DM Quality | 787.00 |
| Global Health | 1470.95 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: